Report recommends insurers embrace attribution science to help quantify the impact.

Insurers urged to monitor clinical trials, the adoption of tests and regulatory uncertainty.

Quebec pharmacists support maintaining a mixed public-private system.

Insurers’ association says the industry is working to reduce the administrative burden on physicians.

If you can manage it, your firm will be more valuable.

Insurers and sponsors tasked with funding new drugs or limiting their usage.

New drug impacts on private drug plans examined in new report.